Given the variations for each person with ALS, what works for one might not be ideal for another, writes columnist.
Hearst en derden gebruiken op deze website cookies en vergelijkbare technologieën ('cookies'). Sommige cookies zijn nodig om ...
NUZ-001 slowed respiratory declines in ALS patients in a Phase 1 trial, and Neurizon is working to ready it for the HEALEY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback